Arundhati Parmar is VP and Editor-in-Chief at MedCity News. In this role, she oversees MedCity's news coverage as well as develops the content for several conferences that the publication hosts.

With more than two decades of experience building strategy, GTM, and growth for payer, provider, medical device, and technology organizations, Susan Taylor, Pega's Vice President of Healthcare ...

The group of four healthcare startups spans women's health, orthopedics, remote patient monitoring for Parkinson's disease, AI, and 3D printing. David Kereiakes, Managing Partner, Windham Venture ...

Andrew Zaleski is a freelance writer near Washington, D.C. He has written for Wired, the Washington Post Magazine, Backchannel, The Atlantic, Politico Magazine, Fortune, and other publications.

BJ Schaknowski, CEO of symplr, is a seasoned software industry executive with more than 25 years of experience in leadership roles across a wide variety of operating functions. A former Marine, he ...

-Dorit Donoviel, Ph.D. is the Director of the Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine. As NASA’s partner for health innovation in deep space, the ...

Maven Clinic, a virtual clinic for women’s and family health, has secured $125 million in Series F funding, the company announced Tuesday. New York City-based Maven Clinic offers support for ...

HLTH, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, spotlights individuals across the healthcare ecosystem from high-powered executives such as Fred Abnousi, the head of ...

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Bayo Curry ...

Bipartisan Congressional scrutiny has shone a harsh spotlight on the many tactics used by pharmacy benefit managers (PBMs) and Big Pharma that contribute to the sky high costs of prescription ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a ...

Advancements in surgical technology and therapeutics have improved outcomes for many cancer patients, resulting in 18 million survivors (and growing). New and more efficacious cancer drugs are ...